Difficulty: Medium
Average Score: 94%
Practice
Which of the following substances is synthesized within vessel walls and inhibits thrombogenesis?
Correct answer
B
Rationale
In this question, the correct answer is B) Prostacyclin (PGI2). Prostacyclin is synthesized within vessel walls and acts to inhibit thrombogenesis by preventing platelet aggregation and promoting vasodilation. It plays a crucial role in maintaining vascular homeostasis and preventing excessive clot formation.
Option A) Thromboxane A2 (TXA2) is actually a potent platelet aggregator synthesized by platelets themselves, promoting clot formation and vasoconstriction. This makes it the opposite of prostacyclin in terms of function.
Option C) Prostaglandin (PGE) is a broad category of lipid compounds that includes both thromboxane A2 and prostacyclin. While some prostaglandins do have anti-thrombotic effects, PGE specifically does not inhibit thrombogenesis like prostacyclin does.
Understanding the synthesis and function of these substances is crucial in the field of safety pharmacology as it directly impacts cardiovascular health and the risk of thrombotic events across the lifespan. Knowing the specific actions of prostacyclin and its role in preventing thrombogenesis can guide healthcare professionals in designing interventions to manage cardiovascular conditions and reduce the risk of adverse events related to clot formation.
Option A) Thromboxane A2 (TXA2) is actually a potent platelet aggregator synthesized by platelets themselves, promoting clot formation and vasoconstriction. This makes it the opposite of prostacyclin in terms of function.
Option C) Prostaglandin (PGE) is a broad category of lipid compounds that includes both thromboxane A2 and prostacyclin. While some prostaglandins do have anti-thrombotic effects, PGE specifically does not inhibit thrombogenesis like prostacyclin does.
Understanding the synthesis and function of these substances is crucial in the field of safety pharmacology as it directly impacts cardiovascular health and the risk of thrombotic events across the lifespan. Knowing the specific actions of prostacyclin and its role in preventing thrombogenesis can guide healthcare professionals in designing interventions to manage cardiovascular conditions and reduce the risk of adverse events related to clot formation.